Non Invasive Prenatal Testing Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (NGS, Array Technology, PCR, Others), By Applications (Hospitals, Clinical Laboratories) , and Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Non Invasive Prenatal Testing Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Non Invasive Prenatal Testing Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Non Invasive Prenatal Testing Business Mode and Production Process
2.3.1 Non Invasive Prenatal Testing Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Non Invasive Prenatal Testing Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Non Invasive Prenatal Testing
2.4.2 Raw Material Cost of Non Invasive Prenatal Testing
2.4.3 Labor Cost of Non Invasive Prenatal Testing
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Non Invasive Prenatal Testing Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Non Invasive Prenatal Testing Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Non Invasive Prenatal Testing Price by Manufacturer (2021-2026)
4.4 Non Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Non Invasive Prenatal Testing, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Non Invasive Prenatal Testing, Product Offered and Application
4.7 Non Invasive Prenatal Testing Market Competitive Situation and Trends
4.7.1 Non Invasive Prenatal Testing Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Non Invasive Prenatal Testing Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Non Invasive Prenatal Testing Market Historical Development by Geographic Region (2021-2026)
5.1 Global Non Invasive Prenatal Testing Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Non Invasive Prenatal Testing Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Non Invasive Prenatal Testing Market Status by Country (2021-2026)
5.3.1 North America Non Invasive Prenatal Testing Sales Volume by Country (2021-2026)
5.3.2 North America Non Invasive Prenatal Testing Revenue by Country (2021-2026)
5.3.3 United States Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Non Invasive Prenatal Testing Market Status by Country (2021-2026)
5.4.1 Europe Non Invasive Prenatal Testing Sales Volume by Country (2021-2026)
5.4.2 Europe Non Invasive Prenatal Testing Revenue by Country (2021-2026)
5.4.3 Germany Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Non Invasive Prenatal Testing Market Status by Country (2021-2026)
5.5.1 Asia Pacific Non Invasive Prenatal Testing Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Non Invasive Prenatal Testing Revenue by Country (2021-2026)
5.5.3 China Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Non Invasive Prenatal Testing Market Status by Country (2021-2026)
5.6.1 Latin America Non Invasive Prenatal Testing Sales Volume by Country (2021-2026)
5.6.2 Latin America Non Invasive Prenatal Testing Revenue by Country (2021-2026)
5.6.3 Mexico Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Non Invasive Prenatal Testing Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Non Invasive Prenatal Testing Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Non Invasive Prenatal Testing Revenue by Country (2021-2026)
5.7.3 GCC Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Non Invasive Prenatal Testing Sales Volume, Revenue and Growth (2021-2026)

6 Global Non Invasive Prenatal Testing Market Historical Development by Product Type (2021-2026)
6.1 Non Invasive Prenatal Testing Definition by Type
6.2 Global Non Invasive Prenatal Testing Historical Sales Volume by Product Type (2021-2026)
6.3 Global Non Invasive Prenatal Testing Historical Revenue by Product Type (2021-2026)
6.4 Global Non Invasive Prenatal Testing Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Non Invasive Prenatal Testing Historical Sales Volume, Revenue and Growth Rate of NGS (2021-2026)
6.5.2 Global Non Invasive Prenatal Testing Historical Sales Volume, Revenue and Growth Rate of Array Technology (2021-2026)
6.5.3 Global Non Invasive Prenatal Testing Historical Sales Volume, Revenue and Growth Rate of PCR (2021-2026)
6.5.4 Global Non Invasive Prenatal Testing Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

7 Global Non Invasive Prenatal Testing Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Non Invasive Prenatal Testing Historical Sales Volume by End User (2021-2026)
7.3 Global Non Invasive Prenatal Testing Historical Revenue by End User (2021-2026)
7.4 Global Non Invasive Prenatal Testing Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Non Invasive Prenatal Testing Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Non Invasive Prenatal Testing Historical Sales Volume, Revenue and Growth Rate of Clinical Laboratories (2021-2026)

8 Leading Companies Profiles
8.1 Myriad Women’s Health, Inc. (Counsyl, Inc.)
8.1.1 Myriad Women’s Health, Inc. (Counsyl, Inc.) Corporation Information
8.1.2 Myriad Women’s Health, Inc. (Counsyl, Inc.) - Non Invasive Prenatal Testing Product Portfolio and Specification
8.1.3 Myriad Women’s Health, Inc. (Counsyl, Inc.) Performance Analysis (2021-2026)
8.1.4 Myriad Women’s Health, Inc. (Counsyl, Inc.) Business and Markets Served
8.1.5 Myriad Women’s Health, Inc. (Counsyl, Inc.) Recent Developments
8.2 Genesis Genetics (CooperSurgical, Inc.)
8.2.1 Genesis Genetics (CooperSurgical, Inc.) Corporation Information
8.2.2 Genesis Genetics (CooperSurgical, Inc.) - Non Invasive Prenatal Testing Product Portfolio and Specification
8.2.3 Genesis Genetics (CooperSurgical, Inc.) Performance Analysis (2021-2026)
8.2.4 Genesis Genetics (CooperSurgical, Inc.) Business and Markets Served
8.2.5 Genesis Genetics (CooperSurgical, Inc.) Recent Developments
8.3 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
8.3.1 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Corporation Information
8.3.2 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) - Non Invasive Prenatal Testing Product Portfolio and Specification
8.3.3 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Performance Analysis (2021-2026)
8.3.4 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Business and Markets Served
8.3.5 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Recent Developments
8.4 Quest Diagnostics, Inc.
8.4.1 Quest Diagnostics, Inc. Corporation Information
8.4.2 Quest Diagnostics, Inc. - Non Invasive Prenatal Testing Product Portfolio and Specification
8.4.3 Quest Diagnostics, Inc. Performance Analysis (2021-2026)
8.4.4 Quest Diagnostics, Inc. Business and Markets Served
8.4.5 Quest Diagnostics, Inc. Recent Developments
8.5 Qiagen
8.5.1 Qiagen Corporation Information
8.5.2 Qiagen - Non Invasive Prenatal Testing Product Portfolio and Specification
8.5.3 Qiagen Performance Analysis (2021-2026)
8.5.4 Qiagen Business and Markets Served
8.5.5 Qiagen Recent Developments
8.6 Centogene N.V.
8.6.1 Centogene N.V. Corporation Information
8.6.2 Centogene N.V. - Non Invasive Prenatal Testing Product Portfolio and Specification
8.6.3 Centogene N.V. Performance Analysis (2021-2026)
8.6.4 Centogene N.V. Business and Markets Served
8.6.5 Centogene N.V. Recent Developments
8.7 Progenity, Inc.
8.7.1 Progenity, Inc. Corporation Information
8.7.2 Progenity, Inc. - Non Invasive Prenatal Testing Product Portfolio and Specification
8.7.3 Progenity, Inc. Performance Analysis (2021-2026)
8.7.4 Progenity, Inc. Business and Markets Served
8.7.5 Progenity, Inc. Recent Developments
8.8 Laboratory Corp. of America Holdings
8.8.1 Laboratory Corp. of America Holdings Corporation Information
8.8.2 Laboratory Corp. of America Holdings - Non Invasive Prenatal Testing Product Portfolio and Specification
8.8.3 Laboratory Corp. of America Holdings Performance Analysis (2021-2026)
8.8.4 Laboratory Corp. of America Holdings Business and Markets Served
8.8.5 Laboratory Corp. of America Holdings Recent Developments
8.9 Natera, Inc.
8.9.1 Natera, Inc. Corporation Information
8.9.2 Natera, Inc. - Non Invasive Prenatal Testing Product Portfolio and Specification
8.9.3 Natera, Inc. Performance Analysis (2021-2026)
8.9.4 Natera, Inc. Business and Markets Served
8.9.5 Natera, Inc. Recent Developments
8.10 Eurofins LifeCodexx GmbH
8.10.1 Eurofins LifeCodexx GmbH Corporation Information
8.10.2 Eurofins LifeCodexx GmbH - Non Invasive Prenatal Testing Product Portfolio and Specification
8.10.3 Eurofins LifeCodexx GmbH Performance Analysis (2021-2026)
8.10.4 Eurofins LifeCodexx GmbH Business and Markets Served
8.10.5 Eurofins LifeCodexx GmbH Recent Developments
8.11 MedGenome Labs Ltd.
8.11.1 MedGenome Labs Ltd. Corporation Information
8.11.2 MedGenome Labs Ltd. - Non Invasive Prenatal Testing Product Portfolio and Specification
8.11.3 MedGenome Labs Ltd. Performance Analysis (2021-2026)
8.11.4 MedGenome Labs Ltd. Business and Markets Served
8.11.5 MedGenome Labs Ltd. Recent Developments
8.12 Illumina, Inc. (Verinata Health, Inc.)
8.12.1 Illumina, Inc. (Verinata Health, Inc.) Corporation Information
8.12.2 Illumina, Inc. (Verinata Health, Inc.) - Non Invasive Prenatal Testing Product Portfolio and Specification
8.12.3 Illumina, Inc. (Verinata Health, Inc.) Performance Analysis (2021-2026)
8.12.4 Illumina, Inc. (Verinata Health, Inc.) Business and Markets Served
8.12.5 Illumina, Inc. (Verinata Health, Inc.) Recent Developments

9 Global Non Invasive Prenatal Testing Market Forecast by Product Type and End User (2026-2034)
9.1 Global Non Invasive Prenatal Testing Market Forecast by Product Type (2026-2034)
9.1.1 Global Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth Rate of NGS (2026-2034)
9.1.2 Global Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth Rate of Array Technology (2026-2034)
9.1.3 Global Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth Rate of PCR (2026-2034)
9.1.4 Global Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Non Invasive Prenatal Testing Market Forecast by End User (2026-2034)
9.2.1 Global Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth Rate of Clinical Laboratories (2026-2034)

10 Global Non Invasive Prenatal Testing Market Forecast by Geographic Region (2026-2034)
10.1 Global Non Invasive Prenatal Testing Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Non Invasive Prenatal Testing Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer